Literature DB >> 16583633

Optical coherence tomography of idiopathic juxtafoveolar telangiectasia.

Thomas A Albini1, Matthew S Benz, Robert E Coffee, Andrew C Westfall, Rohit R Lakhanpal, Alice R McPherson, Eric R Holz.   

Abstract

BACKGROUND AND
OBJECTIVE: To document optical coherence tomography (OCT) findings in a series of eyes with group 2A idiopathic juxtafoveal telangiectasia. PATIENTS AND METHODS: This study is a retrospective review of patient charts, OCT, fundus photography, and fluorescein angiography involving 23 eyes (12 patients). Mean retinal thickness in 9 macular areas was calculated and compared to previously published measurements from normal eyes.
RESULTS: OCT in 8 of 13 stage 3 eyes revealed foveal cysts without evidence of cystoid macular edema on fluorescein angiography or biomicroscopy, and 1 lamellar hole. In stage 3 eyes, mild retinal thickening was found in 7 of 9 macular areas (P < .05).
CONCLUSIONS: OCT commonly reveals foveal cysts in stage 3 idiopathic juxtafoveal telangiectasia. Consistent findings of associated mild macular thickening and lack of late petaloid hyperfluorescence on fluorescein angiography suggest that these cysts differ in pathophysiology from cystoid macular

Entities:  

Mesh:

Year:  2006        PMID: 16583633

Source DB:  PubMed          Journal:  Ophthalmic Surg Lasers Imaging        ISSN: 1542-8877


  11 in total

1.  Idiopathic juxtafoveolar retinal telangiectasis in monozygotic twins.

Authors:  Shabeeba R Hannan; Krishnappa C Madhusudhana; Christina Rennie; Andrew J Lotery
Journal:  Br J Ophthalmol       Date:  2007-12       Impact factor: 4.638

2.  CHARACTERISTICS OF PIGMENTED LESIONS IN TYPE 2 IDIOPATHIC MACULAR TELANGIECTASIA.

Authors:  Irene Leung; Ferenc B Sallo; Roberto Bonelli; Traci E Clemons; Daniel Pauleikhoff; Emily Y Chew; Alan C Bird; Tunde Peto
Journal:  Retina       Date:  2018-01       Impact factor: 4.256

3.  The prevalence of macular telangiectasia type 2 in the Beaver Dam eye study.

Authors:  Ronald Klein; Barbara A Blodi; Stacy M Meuer; Chelsea E Myers; Emily Y Chew; Barbara E K Klein
Journal:  Am J Ophthalmol       Date:  2010-07       Impact factor: 5.258

4.  Retinal vascular density evaluated by optical coherence tomography angiography in macular telangiectasia type 2.

Authors:  Berna Dogan; Muhammet Kazim Erol; Melih Akidan; Elcin Suren; Yusuf Akar
Journal:  Int Ophthalmol       Date:  2019-01-03       Impact factor: 2.031

5.  Prevalence and progression of pigment clumping associated with idiopathic macular telangiectasia type 2.

Authors:  Annal D Meleth; Brian C Toy; Divya Nigam; Elvira Agrón; Robert P Murphy; Emily Y Chew; Wai T Wong
Journal:  Retina       Date:  2013-04       Impact factor: 4.256

6.  Idiopathic juxtafoveolar retinal telangiectasis: a current review.

Authors:  Sawsan R Nowilaty; Hanan N Al-Shamsi; Wajeeha Al-Khars
Journal:  Middle East Afr J Ophthalmol       Date:  2010-07

7.  Fundus autofluorescence in type 2 idiopathic macular telangiectasia: correlation with optical coherence tomography and microperimetry.

Authors:  Wai T Wong; Farzin Forooghian; Zigurts Majumdar; Robert F Bonner; Denise Cunningham; Emily Y Chew
Journal:  Am J Ophthalmol       Date:  2009-07-02       Impact factor: 5.258

Review 8.  Macular telangiectasia type 2.

Authors:  Peter Charbel Issa; Mark C Gillies; Emily Y Chew; Alan C Bird; Tjebo F C Heeren; Tunde Peto; Frank G Holz; Hendrik P N Scholl
Journal:  Prog Retin Eye Res       Date:  2012-12-03       Impact factor: 21.198

9.  Comparison of observation, intravitreal bevacizumab, or pars plana vitrectomy for non-proliferative type 2 idiopathic macular telangiectasia.

Authors:  Eric J Sigler; John C Randolph; Jorge I Calzada; Steve Charles
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-09-06       Impact factor: 3.117

Review 10.  Multimodality imaging in macular telangiectasia 2: A clue to its pathogenesis.

Authors:  Lihteh Wu
Journal:  Indian J Ophthalmol       Date:  2015-05       Impact factor: 1.848

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.